Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |